Imatinib tablets

DRUG3 trials

Sponsors

Novartis, Hospital Universitario de Fuenlabrada, Centre Leon Berard

Conditions

Advanced Gastrointestinal Stromal Tumor (GIST)C-KIT MutationCOVID-19 PneumoniaMetastatic Gastrointestinal Stromal Tumor (GIST)Recurrent Glioblastoma Multiforme (GBM)

Phase 2

Efficacy and Safety of Imatinib Mesylate Plus Hydroxyurea (HU) in Patients With Recurrent Glioblastoma Multiforme (GBM)

TerminatedNCT00290771

NovartisRecurrent Glioblastoma Multiforme (GBM)

Start: 2006-02-28End: 2008-08-31Updated: 2011-05-16

Clinical Trial to Evaluate Efficacy of 3 Types of Treatment in Patients With Pneumonia by COVID-19

Hospital Universitario de FuenlabradaCOVID-19 Pneumonia

Start: 2020-05-07End: 2021-09-30Updated: 2021-08-03

Efficiency of Imatinib Treatment After 10 Years of Treatment in Patients With Gastrointestinal Stromal Tumours (GIST) (Gist-Ten)

RecruitingNCT05009927

Centre Leon BerardAdvanced Gastrointestinal Stromal Tumor (GIST), C-KIT Mutation, Metastatic Gastrointestinal Stromal Tumor (GIST)

Start: 2022-01-03End: 2027-01-31Target: 50Updated: 2023-09-01

Related Papers

Imatinib in patients with severe COVID-19: a randomised, double-blind, placebo-controlled, clinical trial.

2021-06-1887 citations